Literature DB >> 20108334

Severity of health conditions identified in a pediatric cancer survivor program.

Karen Wasilewski-Masker1, Ann C Mertens, Briana Patterson, Lillian R Meacham.   

Abstract

BACKGROUND: The Common Terminology Criteria for Adverse Events v3.0 (CTCAE) was designed for reporting acute and late effects of cancer treatment. To date, no study of pediatric-aged cancer survivors has graded health conditions using CTCAE, for patients in active follow-up in a cancer survivor program. PROCEDURE: Medical records were reviewed on 519 survivors of non-central nervous system childhood malignancies seen in the Cancer Survivor Program between January 1, 2001 and December 15, 2005. Health problems identified through histories, physicals, and recommended evaluation using the Children's Oncology Group (COG) Long-Term Follow-Up Guidelines for Survivors of Childhood, Adolescent and Young Adult Cancer were graded using the CTCAE.
RESULTS: Overall, 1,625 adverse health conditions were reported or detected in 519 pediatric-age cancer survivors (mean age at diagnosis 4.8 years; mean age at first survivor visit 12.1 years). The majority of conditions were mild (47.4% Grade 1) or moderate (35.2% Grade 2); however, 17.4% of conditions were severe (Grade 3) or life-threatening/disabling (Grade 4). Only 12.1% of survivors had no adverse condition, and 36.2% of survivors had a Grade 3 or 4 condition. In a Cox multivariate analysis risk factors for a Grade 3 or 4 condition included minority race, diagnosis of other malignancy, older age, and a history of a hematopoietic stem cell transplant.
CONCLUSIONS: The majority of adverse health conditions in pediatric-aged cancer survivors are mild; however, a significant percentage will have a serious condition. Long-term follow-up with a multidisciplinary approach is essential to detect and intervene in health problems early. Copyright 2010 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20108334     DOI: 10.1002/pbc.22431

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN: 1545-5009            Impact factor:   3.167


  14 in total

1.  Computerized provider order entry in pediatric oncology: design, implementation, and outcomes.

Authors:  Allen R Chen; Christoph U Lehmann
Journal:  J Oncol Pract       Date:  2011-07       Impact factor: 3.840

2.  American Society of Clinical Oncology policy statement update: the critical role of phase I trials in cancer research and treatment.

Authors:  Jeffrey S Weber; Laura A Levit; Peter C Adamson; Suanna Bruinooge; Howard A Burris; Michael A Carducci; Adam P Dicker; Mithat Gönen; Stephen M Keefe; Michael A Postow; Michael A Thompson; David M Waterhouse; Susan L Weiner; Lynn M Schuchter
Journal:  J Clin Oncol       Date:  2014-12-15       Impact factor: 44.544

3.  Late effect clinic - An integral part of childhood cancer treatment.

Authors:  Dubashi Biswajit
Journal:  J Young Pharm       Date:  2013-12

4.  Self-reported late effect symptom clusters among young pediatric cancer survivors.

Authors:  Rebecca Williamson Lewis; Karen E Effinger; Karen Wasilewski-Masker; Ann Mertens; Canhua Xiao
Journal:  Support Care Cancer       Date:  2021-07-06       Impact factor: 3.603

5.  Clinical Trial Enrollment is Associated With Improved Follow-up Rates Among Survivors of Childhood Cancer.

Authors:  Kelley K Hutchins; Süreyya Savaşan; Ronald L Thomas; Laura A Strathdee; Zhihong J Wang; Jeffrey W Taub
Journal:  J Pediatr Hematol Oncol       Date:  2019-01       Impact factor: 1.289

6.  Yield of screening for long-term complications using the children's oncology group long-term follow-up guidelines.

Authors:  Wendy Landier; Saro H Armenian; Jin Lee; Ola Thomas; F Lennie Wong; Liton Francisco; Claudia Herrera; Clare Kasper; Karla D Wilson; Meghan Zomorodi; Smita Bhatia
Journal:  J Clin Oncol       Date:  2012-10-22       Impact factor: 44.544

Review 7.  Developing interventions for cancer-related cognitive dysfunction in childhood cancer survivors.

Authors:  Sharon M Castellino; Nicole J Ullrich; Megan J Whelen; Beverly J Lange
Journal:  J Natl Cancer Inst       Date:  2014-07-30       Impact factor: 13.506

8.  Clinical ascertainment of health outcomes among adults treated for childhood cancer.

Authors:  Melissa M Hudson; Kirsten K Ness; James G Gurney; Daniel A Mulrooney; Wassim Chemaitilly; Kevin R Krull; Daniel M Green; Gregory T Armstrong; Kerri A Nottage; Kendra E Jones; Charles A Sklar; Deo Kumar Srivastava; Leslie L Robison
Journal:  JAMA       Date:  2013-06-12       Impact factor: 56.272

Review 9.  Survivors of childhood and adolescent cancer: life-long risks and responsibilities.

Authors:  Leslie L Robison; Melissa M Hudson
Journal:  Nat Rev Cancer       Date:  2013-12-05       Impact factor: 60.716

10.  Late somatic sequelae after treatment of childhood cancer in Slovenia.

Authors:  Nuša Erman; Ljupčo Todorovski; Berta Jereb
Journal:  BMC Res Notes       Date:  2012-05-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.